C5 and myasthenia gravis: MAC deposition (Figs. 4B and C and Supplementary Figure 3) and soluble complement split products, C5a (Fig. 4D) and sC5b9 (Fig. 4E), were detected from the 3D skeletal muscle tissues treated with MG sera.